医学
免疫
肾
免疫学
肾移植
肾移植
免疫系统
内科学
作者
Inge Jonkman,Maaike Jacobs,Yutaka Negishi,Cansu Yanginlar,Joost H.A. Martens,Marijke P. Baltissen,Michiel Vermeulen,Martijn W.F. van den Hoogen,Marije C. Baas,Johan van der Vlag,Zahi A. Fayad,Abraham J. P. Teunissen,Joren C. Madsen,Jordi Ochando,Leo A. B. Joosten,Mihai G. Netea,Willem J. M. Mulder,Musa M. Mhlanga,Luuk B. Hilbrands,Nils Rother,Raphaël Duivenvoorden
标识
DOI:10.1016/j.ajt.2024.08.006
摘要
The innate immune system plays an essential role in regulating the immune responses to kidney transplantation, but the mechanisms through which innate immune cells influence long-term graft survival are unclear. The current study highlights the vital role of trained immunity in kidney allograft survival. Trained immunity describes the epigenetic and metabolic changes that innate immune cells undergo following an initial stimulus, allowing them have a stronger inflammatory response to subsequent stimuli. We stimulated healthy peripheral blood mononuclear cells with pretransplant and posttransplant serum of kidney transplant patients and immunosuppressive drugs in an in vitro trained immunity assay and measured tumor necrosis factor and interleukin 6 cytokine levels in the supernatant as a readout for trained immunity. We show that the serum of kidney transplant recipients collected 1 week after transplantation can suppress trained immunity. Importantly, we found that kidney transplant recipients whose serum most strongly suppressed trained immunity rarely experienced graft loss. This suppressive effect of posttransplant serum is likely mediated by previously unreported effects of immunosuppressive drugs. Our findings provide mechanistic insights into the role of innate immunity in kidney allograft survival, uncovering trained immunity as a potential therapeutic target for improving graft survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI